Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa

Tropical Medicine and International Health

Volumn 15, Issue SUPPL. 1, 2010, Pages 43-47

  Larson, Bruce A ^a   Brennan, Alana ^a   McNamara, Lynne ^b   Long, Lawrence ^b   Rosen, Sydney ^a   Sanne, Ian ^b   Fox, Matthew P ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

HIV care; Pre antiretroviral therapy loss to follow up; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TREATMENT; DRUG PRESCRIBING; HEALTH RISK; HEALTH SERVICES; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE; PUBLIC HEALTH;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH CENTER; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT IDENTIFICATION; PATIENT MONITORING; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SOUTH AFRICA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LONG-TERM CARE; LOST TO FOLLOW-UP; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PROGRAM EVALUATION; SOUTH AFRICA;

GAUTENG; JOHANNESBURG; SOUTH AFRICA;

EID: 77951775896     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02511.x     Document Type: Article

References (19)

1. Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9, 290.
2. Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban South Africa. Journal of Acquired Immune Deficiency Syndromes 51, 135 139.
3. Egger M (2007) Outcomes of antiretroviral treatment in resource limited and industrialized countries (Abstract 62). 14th Conference on Retroviruses and Opportunistic Infections
4. Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine 168, 86 93.
5. Horne R, Cooper V, Gellaitry G, Date H Fisher M (2007) Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndrome 45, 334 341.
6. Jones P (2005) On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia. Health and Human Rights 8, 76 102.
7. Kigozi IM, Dobkin LM, Martin JN et al. (2010) Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 52, 280 289.
8. Kinsler J, Wong M, Sayles J, Davis C Cunningham W (2007) The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. Aids Patient Care and STDS 21, 584 592.
9. Larson BA, Brennan A, Mcnamara L et al. (2009) A Lost Opportunity: Most VCT Patients Who Test Positive for HIV in a Large South African Clinic do not Initiate HIV Care. Boston, University
10. Lawn S, D Myer L, Orrell C, Bekker LG Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19, 2141 2148.
11. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG Wood R (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 43, 770 776.
12. Makombe SD, Jahn A, Tweya H et al. (2007) A national survey of teachers on antiretroviral therapy in Malawi: access retention in therapy and survival. PLoS ONE 2, e620.
13. Mcnutt LA, Wu C, Xue X Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 157, 940 943.
14. Mshana GH, Wamoyi J, Busza J et al. (2006) Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 20, 649 657.
15. Muula A, Ngulube T, Siziya S et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7, 63.
16. Rosen S, Long L Sanne I (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Tropical Medicine & International Health 13, 1 11.
17. South African National Department of Health (2007) HIV and AIDS and STI Strategic Plan for South Africa 2007-2011. MoH
18. Wilson D Blower S (2007) How far will we need to go to reach HIV-infected people in rural South Africa? BMC Medicine 5, 16.
19. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 159, 702 706.